Annual change in FEV1 in elderly 10-year survivors with established chronic obstructive pulmonary disease

Author:

Suzuki MasaruORCID,Makita Hironi,Konno Satoshi,Shimizu Kaoruko,Nasuhara Yasuyuki,Nagai Katsura,Akiyama Yasushi,Fuke Satoshi,Saito Hiroshi,Igarashi Takeshi,Takeyabu Kimihiro,Nishimura Masaharu

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference24 articles.

1. Global Initiative for Chronic Obstructive Lung Disease [Internet]. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2018 report, Available from: http://www.goldcopd.org [revised 2017 November 15; accessed 2017 December 7].

2. Fletcher, C. & Peto, R. The natural history of chronic airflow obstruction. B.M.J. 1, 1645–1648 (1977).

3. Fletcher, C. M., Peto, R., Tinker, C. M. & Speizer, F. E. The natural history of chronic bronchitis and emphysema (Oxford University Press, 1976).

4. Celli, B. R. et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 178, 332–338 (2008).

5. Tashkin, D. P. et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med. 359, 1543–1554 (2008).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3